Page last updated: 2024-08-23

androstane-3,17-diol and Hypergonadotropic Hypogonadism

androstane-3,17-diol has been researched along with Hypergonadotropic Hypogonadism in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19906 (85.71)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cobey, K; Coelingh Bennink, HJ; Fauser, BC; Foidart, JM; Minon, JM; Pintiaux, A; Zimmerman, Y1
Anderson, DC; Cantrill, JA; Dewis, P; Large, DM; Newman, M1
Stahl, F1
Bundschu, HD; Hayduk, K; Heller, S; Liebau, G; Lüders, G; Pfeiffer, EH; Rager, K1
Dolman, LI; Lagerquist, LG; Meikle, AW; Stringham, JD; Tyler, FH1
O'Shaughnessy, PJ; Sheffield, JW1
Ahmed, SR; Bartholomew, M; Boucher, AE; Demers, LM; Manni, A; Santen, RJ1

Reviews

1 review(s) available for androstane-3,17-diol and Hypergonadotropic Hypogonadism

ArticleYear
[The determination, secretion and plasma concentration of androgens].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1979, Oct-15, Volume: 34, Issue:20

    Topics: Adolescent; Adult; Age Factors; Androgen Antagonists; Androgen-Binding Protein; Androgens; Androstane-3,17-diol; Androstenedione; Child; Dehydroepiandrosterone; Dihydrotestosterone; Female; Humans; Hypogonadism; Infant; Male; Pregnancy; Radioimmunoassay; Sex Factors; Testosterone; Virilism

1979

Trials

1 trial(s) available for androstane-3,17-diol and Hypergonadotropic Hypogonadism

ArticleYear
Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects.
    Contraception, 2015, Volume: 91, Issue:2

    Topics: Adolescent; Adult; Androgen Antagonists; Androstane-3,17-diol; Androstenedione; Androstenes; Belgium; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypogonadism; Sex Hormone-Binding Globulin; Solubility; Testosterone; Up-Regulation; Young Adult

2015

Other Studies

5 other study(ies) available for androstane-3,17-diol and Hypergonadotropic Hypogonadism

ArticleYear
Which testosterone replacement therapy?
    Clinical endocrinology, 1984, Volume: 21, Issue:2

    Topics: Administration, Oral; Adult; Aged; Androstane-3,17-diol; Dihydrotestosterone; Drug Implants; Estradiol; Humans; Hypogonadism; Injections, Intramuscular; Male; Middle Aged; Testosterone

1984
[Effects of longterm HCG administration on testicular function in hemodialysis patients (author's transl)].
    Klinische Wochenschrift, 1976, Nov-01, Volume: 54, Issue:21

    Topics: Adult; Androstane-3,17-diol; Cell Count; Chorionic Gonadotropin; Dihydrotestosterone; Follicle Stimulating Hormone; Humans; Hypogonadism; Kidney Failure, Chronic; Long-Term Care; Luteinizing Hormone; Male; Middle Aged; Renal Dialysis; Spermatozoa; Testosterone

1976
Plasma 5alpha androstanediol: an androgen marker of hirsuitism in women.
    Transactions of the Association of American Physicians, 1976, Volume: 89

    Topics: Adolescent; Adult; Androstane-3,17-diol; Androstanes; Dexamethasone; Diethylstilbestrol; Estradiol Congeners; Female; Hirsutism; Humans; Hypogonadism; Male; Progestins; Testosterone

1976
Effect of injection of gonadotrophin-releasing hormone on testicular steroidogenesis in the hypogonadal (hpg) mouse.
    Journal of reproduction and fertility, 1989, Volume: 86, Issue:2

    Topics: Androgens; Androstane-3,17-diol; Androstenedione; Animals; Hypogonadism; Male; Mice; Mice, Mutant Strains; Pituitary Hormone-Releasing Hormones; Testis; Testosterone

1989
Transdermal testosterone therapy in the treatment of male hypogonadism.
    The Journal of clinical endocrinology and metabolism, 1988, Volume: 66, Issue:3

    Topics: Administration, Cutaneous; Androstane-3,17-diol; Dihydrotestosterone; Estradiol; Humans; Hypogonadism; Male; Testosterone

1988